International Paper projects $4B EBITDA target with DS Smith integration and cost reductions
Q4 2024 . Management View. CEO Andrew Silvernail announced the anticipated completion of the DS Smith acquisition by ...
Incyte's SWOT analysis: stock faces patent cliff challenge amid pipeline promise
Corporation, a biopharmaceutical company specializing in the discovery, development, and commercialization of proprietary ...